{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:33:22Z","timestamp":1780918402898,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18102-x","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:18:05Z","timestamp":1758885485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combined albumin and CEA improve prognostic prediction in resectable gastric cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianshi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"2","key":"18102_CR1","first-page":"115","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Cancer statistics in China, 2015. CA Cancer J. Clin. 66(2), 115\u2013132 (2016).","journal-title":"CA Cancer J. Clin."},{"issue":"26","key":"18102_CR2","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.3748\/wjg.v24.i26.2818","volume":"24","author":"T Matsuoka","year":"2018","unstructured":"Matsuoka, T. & Yashiro, M. Biomarkers of gastric cancer: Current topics and future perspective. World J. Gastroenterol. 24(26), 2818\u20132832 (2018).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"18102_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40880-016-0122-2","volume":"35","author":"X Sun","year":"2016","unstructured":"Sun, X. et al. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I\u2013II gastric cancer. Chin. J. Cancer 35(1), 57 (2016).","journal-title":"Chin. J. Cancer"},{"issue":"3","key":"18102_CR4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/SLA.0000000000001743","volume":"265","author":"JC Chan","year":"2017","unstructured":"Chan, J. C. et al. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann. Surg. 265(3), 539\u2013546 (2017).","journal-title":"Ann. Surg."},{"issue":"3","key":"18102_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5009\/gnl17216","volume":"12","author":"BM Lee","year":"2018","unstructured":"Lee, B. M. et al. The neutrophil\u2013lymphocyte ratio and platelet\u2013lymphocyte ratio are prognostic factors in patients with locally advanced pancreatic cancer treated with chemoradiotherapy. Gut Liver 12(3), 342\u2013352 (2018).","journal-title":"Gut Liver"},{"key":"18102_CR6","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.2147\/OTT.S140872","volume":"10","author":"J Peng","year":"2017","unstructured":"Peng, J. et al. Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival. Onco Targets Ther. 10, 3789\u20133799 (2017).","journal-title":"Onco Targets Ther."},{"issue":"2","key":"18102_CR7","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.21873\/anticanres.13217","volume":"39","author":"M Yamamoto","year":"2019","unstructured":"Yamamoto, M. et al. Combination of serum albumin and cholinesterase levels as prognostic indicator in patients ith colorectal cancer. Anticancer Res. 39(2), 1085\u20131090 (2019).","journal-title":"Anticancer Res."},{"key":"18102_CR8","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.2147\/CMAR.S191432","volume":"11","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. Prognostic values of preoperative platelet-to-lymphocyte ratio, albumin and hemoglobin in patients with non-metastatic colon cancer. Cancer Manag. Res. 11, 3265\u20133274 (2019).","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"18102_CR9","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1038\/s41598-017-03153-6","volume":"7","author":"J Hang","year":"2017","unstructured":"Hang, J. et al. Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients. Sci. Rep. 7(1), 2993 (2017).","journal-title":"Sci. Rep."},{"issue":"7","key":"18102_CR10","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/1759-7714.13107","volume":"10","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. The prognostic value of the preoperative albumin to alkaline phosphatase ratio in patients with non-small cell lung cancer after surgery. Thorac. Cancer 10(7), 1581\u20131589 (2019).","journal-title":"Thorac. Cancer"},{"issue":"1","key":"18102_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12885-017-3220-x","volume":"17","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. The prognostic value of the preoperative c-reactive protein\/albumin ratio in ovarian cancer. BMC Cancer 17(1), 285 (2017).","journal-title":"BMC Cancer"},{"issue":"6","key":"18102_CR12","first-page":"7417","volume":"14","author":"M Mao","year":"2017","unstructured":"Mao, M. et al. C-reactive protein\/albumin and neutrophil\/lymphocyte ratios and their combination predict overall survival in patients with gastric cancer. Oncol. Lett. 14(6), 7417\u20137424 (2017).","journal-title":"Oncol. Lett."},{"issue":"3","key":"18102_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1084\/jem.121.3.439","volume":"121","author":"P Gold","year":"1965","unstructured":"Gold, P. & Freedman, S. O. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J. Exp. Med. 121(3), 439\u2013462 (1965).","journal-title":"J. Exp. Med."},{"issue":"23","key":"18102_CR14","doi-asserted-by":"publisher","first-page":"15647","DOI":"10.1074\/jbc.M800543200","volume":"283","author":"SN Thomas","year":"2008","unstructured":"Thomas, S. N. et al. Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J. Biol. Chem. 283(23), 15647\u201315655 (2008).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"18102_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000012001","volume":"57","author":"D Marrelli","year":"1999","unstructured":"Marrelli, D. et al. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 57(1), 55\u201362 (1999).","journal-title":"Oncology"},{"issue":"2","key":"18102_CR16","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0092-8674(89)90970-7","volume":"57","author":"S Benchimol","year":"1989","unstructured":"Benchimol, S. et al. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57(2), 327\u2013334 (1989).","journal-title":"Cell"},{"issue":"1","key":"18102_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1186\/s12885-017-3738-y","volume":"17","author":"F Feng","year":"2017","unstructured":"Feng, F. et al. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. BMC Cancer 17(1), 737 (2017).","journal-title":"BMC Cancer"},{"key":"18102_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1471-230X-13-87","volume":"13","author":"CZ He","year":"2013","unstructured":"He, C. Z. et al. Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer. BMC Gastroenterol. 13, 87 (2013).","journal-title":"BMC Gastroenterol."},{"issue":"31","key":"18102_CR19","doi-asserted-by":"publisher","first-page":"49565","DOI":"10.18632\/oncotarget.10391","volume":"7","author":"Y Liang","year":"2016","unstructured":"Liang, Y. et al. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer. Oncotarget 7(31), 49565\u201349573 (2016).","journal-title":"Oncotarget"},{"issue":"23","key":"18102_CR20","doi-asserted-by":"publisher","first-page":"35423","DOI":"10.18632\/oncotarget.8770","volume":"7","author":"W Wang","year":"2016","unstructured":"Wang, W. et al. Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma. Oncotarget 7(23), 35423\u201335436 (2016).","journal-title":"Oncotarget"},{"issue":"1","key":"18102_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4143\/crt.2008.40.1.16","volume":"40","author":"SH Park","year":"2008","unstructured":"Park, S. H. et al. Prognostic significance of serum and tissue carcinoembryonic antigen in patients with gastric adenocarcinomas. Cancer Res. Treat. 40(1), 16\u201321 (2008).","journal-title":"Cancer Res. Treat."},{"issue":"4","key":"18102_CR22","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.18632\/oncotarget.23307","volume":"9","author":"J Guo","year":"2018","unstructured":"Guo, J. et al. A novel classifier based on three preoperative tumor markers predicting the cancer-specific survival of gastric cancer (CEA, CA19-9 and CA72-4). Oncotarget 9(4), 4814\u20134822 (2018).","journal-title":"Oncotarget"},{"issue":"5","key":"18102_CR23","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.21037\/jgo-23-599","volume":"14","author":"X Luo","year":"2023","unstructured":"Luo, X. et al. High albumin\u2013bilirubin grade predicts worse short-term complications in gastric cancer patients with metabolic syndrome: A retrospective study. J. Gastrointest. Oncol. 14(5), 2039\u20132047 (2023).","journal-title":"J. Gastrointest. Oncol."},{"issue":"19","key":"18102_CR24","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.3748\/wjg.v21.i19.5961","volume":"21","author":"KY Sun","year":"2015","unstructured":"Sun, K. Y. et al. Novel immunological and nutritional-based prognostic index for gastric cancer. World J. Gastroenterol. 21(19), 5961\u20135971 (2015).","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"18102_CR25","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/clinchem\/47.4.624","volume":"47","author":"MJ Duffy","year":"2001","unstructured":"Duffy, M. J. Carcinoembryonic antigen as a marker for colorectal cancer: Is it clinically useful?. Clin. Chem. 47(4), 624\u2013630 (2001).","journal-title":"Clin. Chem."},{"issue":"7","key":"18102_CR26","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.7150\/jca.67600","volume":"13","author":"X Qiu","year":"2022","unstructured":"Qiu, X. et al. Prognostic value of the combination of HB (hemoglobin) and CEA in resectable gastric cancer. J. Cancer 13(7), 2246\u20132257 (2022).","journal-title":"J. Cancer"},{"key":"18102_CR27","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.2147\/CMAR.S246566","volume":"12","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Prognostic value of the combination of CEA and fibrinogen\/albumin ratio in resectable gastric cancer. Cancer Manag. Res. 12, 2767\u20132775 (2020).","journal-title":"Cancer Manag. Res."},{"issue":"12","key":"18102_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.4240\/wjgs.v7.i12.370","volume":"7","author":"B Nazha","year":"2015","unstructured":"Nazha, B. et al. Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate?. World J. Gastrointest. Surg. 7(12), 370\u2013377 (2015).","journal-title":"World J. Gastrointest. Surg."},{"key":"18102_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1472-6890-13-12","volume":"13","author":"PC Chandrasinghe","year":"2013","unstructured":"Chandrasinghe, P. C. et al. Pre-operative hypoalbuminaemia predicts poor overall survival in rectal cancer: A retrospective cohort analysis. BMC Clin. Pathol. 13, 12 (2013).","journal-title":"BMC Clin. Pathol."},{"issue":"2","key":"18102_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1245\/s10434-006-9093-x","volume":"14","author":"LF O\u00f1ate-Oca\u00f1a","year":"2007","unstructured":"O\u00f1ate-Oca\u00f1a, L. F. et al. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann. Surg. Oncol. 14(2), 381\u2013389 (2007).","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"18102_CR31","first-page":"163","volume":"43","author":"SD Heys","year":"1998","unstructured":"Heys, S. D. et al. Serum albumin: A prognostic indicator in patients with colorectal cancer. J. R. Coll. Surg. Edinb. 43(3), 163\u2013168 (1998).","journal-title":"J. R. Coll. Surg. Edinb."},{"issue":"5","key":"18102_CR32","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.amjsurg.2013.03.007","volume":"206","author":"BN Azab","year":"2013","unstructured":"Azab, B. N. et al. Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patients. Am. J. Surg. 206(5), 764\u2013770 (2013).","journal-title":"Am. J. Surg."},{"issue":"7","key":"18102_CR33","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3390\/cancers12071986","volume":"12","author":"AS Almasaudi","year":"2020","unstructured":"Almasaudi, A. S. et al. Hypoalbuminemia reflects nutritional risk, body composition and systemic inflammation and is independently associated with survival in patients with colorectal cancer. Cancers (Basel) 12(7), 1986 (2020).","journal-title":"Cancers (Basel)"},{"issue":"2","key":"18102_CR34","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1207\/S15327914nc392_8","volume":"39","author":"DC McMillan","year":"2001","unstructured":"McMillan, D. C. et al. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr. Cancer 39(2), 210\u2013213 (2001).","journal-title":"Nutr. Cancer"},{"issue":"6","key":"18102_CR35","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.0894-0959.2004.17603.x","volume":"17","author":"BR Don","year":"2004","unstructured":"Don, B. R. & Kaysen, G. Serum albumin: Relationship to inflammation and nutrition. Semin. Dial. 17(6), 432\u2013437 (2004).","journal-title":"Semin. Dial."},{"issue":"2","key":"18102_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.clnu.2009.11.010","volume":"29","author":"GL Jensen","year":"2010","unstructured":"Jensen, G. L. et al. Adult starvation and disease-related malnutrition: A proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee. Clin. Nutr. 29(2), 151\u2013153 (2010).","journal-title":"Clin. Nutr."},{"issue":"7","key":"18102_CR37","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jand.2017.04.018","volume":"117","author":"W Marcason","year":"2017","unstructured":"Marcason, W. Should albumin and prealbumin be used as indicators for malnutrition?. J. Acad. Nutr. Diet. 117(7), 1144 (2017).","journal-title":"J. Acad. Nutr. Diet."},{"key":"18102_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1475-2891-9-69","volume":"9","author":"D Gupta","year":"2010","unstructured":"Gupta, D. & Lis, C. G. Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutr. J. 9, 69 (2010).","journal-title":"Nutr. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18102-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18102-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18102-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:18:06Z","timestamp":1758885486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18102-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18102"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18102-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors approved the final manuscript and the submission to this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"33118"}}